| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |